Showing 14,721 - 14,740 results of 34,357 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.99s Refine Results
  1. 14721

    Table_1_Dose-response relationship between iTBS and prefrontal activation during executive functioning: A fNIRS study.docx by Bella B. B. Zhang (14280854)

    Published 2022
    “…All participants received a single session iTBS over the left DLPFC at intensities of 50, 70, or 100% of their individual resting motor threshold (RMT), each on separate visits. …”
  2. 14722

    Image_1_Changes in fecal microbiota composition and the cytokine expression profile in school-aged children with depression: A case-control study.jpeg by Zongxin Ling (155251)

    Published 2022
    “…We also identified the presence of a complex inflammatory condition in children with depression, characterized by increased levels of pro-inflammatory cytokines such as IL-17 and decreased levels of anti-inflammatory cytokines such as IFN-γ. …”
  3. 14723

    Table_1_Changes in fecal microbiota composition and the cytokine expression profile in school-aged children with depression: A case-control study.docx by Zongxin Ling (155251)

    Published 2022
    “…We also identified the presence of a complex inflammatory condition in children with depression, characterized by increased levels of pro-inflammatory cytokines such as IL-17 and decreased levels of anti-inflammatory cytokines such as IFN-γ. …”
  4. 14724
  5. 14725

    Supplementary Material for: Epidemiological and Treatment Trends for Acute Ischemic Stroke Preceding and during the COVID-19 Pandemic by Rodrigues A. (11465470)

    Published 2021
    “…The database contains the longitudinal healthcare claims of approximately 77 million patients covered by a major insurance provider between 2003 and June 30, 2020 across all 50 states. …”
  6. 14726

    Supplementary Material for: Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropos... by Murt A. (9984845)

    Published 2022
    “…The initial seropositivity rate was 90.9% with inactivated vaccine and 100% with mRNA vaccine. Seropositivity decreased to 44.4% after 6 months, and a booster dose helped in maintaining the 100% of seropositivity (<i>p</i> = 0.005). …”
  7. 14727

    Classification of Anti-HlyE IgG Responses. by Jo Walker (22404069)

    Published 2025
    “…Panels in the top, middle, and bottom rows correspond to the Bangladesh, Malawi, and Nepal study sites, respectively. In each panel, each point represents the anti-HlyE IgG at baseline (x-axis) and the change in IgG from baseline to the follow-up visit (y-axis) of a single participant. …”
  8. 14728
  9. 14729
  10. 14730
  11. 14731
  12. 14732
  13. 14733

    Table_1_Acupuncture for premature ventricular complexes without ischemic or structural heart diseases: A systematic review and meta-analysis of clinical and pre-clinical evidence.D... by Yiyi Cai (6638486)

    Published 2022
    “…Primary outcomes are the number of premature ventricular beats (PVBs) and effective rate defined as “the proportion of participants with over 50% decrease in the number of PVBs from baseline to the end of treatment measured by 24-h Holter”.…”
  14. 14734

    Table_2_Acupuncture for premature ventricular complexes without ischemic or structural heart diseases: A systematic review and meta-analysis of clinical and pre-clinical evidence.D... by Yiyi Cai (6638486)

    Published 2022
    “…Primary outcomes are the number of premature ventricular beats (PVBs) and effective rate defined as “the proportion of participants with over 50% decrease in the number of PVBs from baseline to the end of treatment measured by 24-h Holter”.…”
  15. 14735

    Table_3_Acupuncture for premature ventricular complexes without ischemic or structural heart diseases: A systematic review and meta-analysis of clinical and pre-clinical evidence.D... by Yiyi Cai (6638486)

    Published 2022
    “…Primary outcomes are the number of premature ventricular beats (PVBs) and effective rate defined as “the proportion of participants with over 50% decrease in the number of PVBs from baseline to the end of treatment measured by 24-h Holter”.…”
  16. 14736

    Table_4_Acupuncture for premature ventricular complexes without ischemic or structural heart diseases: A systematic review and meta-analysis of clinical and pre-clinical evidence.D... by Yiyi Cai (6638486)

    Published 2022
    “…Primary outcomes are the number of premature ventricular beats (PVBs) and effective rate defined as “the proportion of participants with over 50% decrease in the number of PVBs from baseline to the end of treatment measured by 24-h Holter”.…”
  17. 14737

    Comparative analysis of different doses of coherent light (laser) and non-coherent light (light-emitting diode) on cellular necrosis and apoptosis: a study in vitro by Vanessa dos Santos Silva (6147899)

    Published 2018
    “…At t24, the LED 40J/cm2 (80±20%, p<0.05) group also showed more necrosis than the control and lower dose groups (laser 10, 20, and 30J/cm2 percentage of 6±4, 10±3 and 7±3%, p<0.05; LED 10 and 20J/cm2 percentage of 3±1 and 17±10%, p<0.05). A decrease in apoptotic cells was observed in the laser group with doses of 10, 40, and 50J/cm2 (6±4, 3±1 and 1±1% respectively, not significant), as well as in the LED 40J/cm2 (2±2%, not significant) group versus control. …”
  18. 14738

    Table_1_Short Body Height and Pre-pregnancy Overweight for Increased Risk of Gestational Diabetes Mellitus: A Population-Based Cohort Study.DOC by Jing Li (10611)

    Published 2018
    “…The risk of GDM increased rapidly with a decreasing height from 158 cm and downwards. …”
  19. 14739

    DataSheet1_Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study.DOCX by Si-Chun Gu (12135735)

    Published 2022
    “…</p><p>Results: Generalized estimating equation analyses revealed that the PCG group had significantly better improvement in UPDRS-III score at T1, T2, and T3 [time-by-group interaction, T1: β, −0.92 (95% CI, −1.59–−0.25; p = 0.01); T2: β, −2.08 (95% CI, −2.90–−1.27; p < 0.001); T3: β, −4.54 (95% CI, −5.37–−3.71; p < 0.001))]. The PCG group showed a greater decrease (rate of disease change) in the total UPDRS score between T0 and T2 [−2.23 (95% CI, −2.72–−1.73; p < 0.001) points per week vs. −0.21 (95% CI, −0.80–0.39; p = 0.50) points per week in the placebo group, p < 0.001]. …”
  20. 14740